We use cookies to understand site performance and improve follow-up from our team.

    Ask an expert

    What is a CPSR, and what evidence does it require?

    The Cosmetic Product Safety Report is the safety assessment at the heart of every cosmetic PIF in the EU and UK. Part A is the data. Part B is the safety assessor's reasoned conclusion. Both must exist before the product can be placed on the market, and both must be kept current.

    Quick answer

    A CPSR (Cosmetic Product Safety Report) is the safety assessment required under Annex I of Regulation (EC) 1223/2009 and the equivalent UK regulation. Part A compiles the safety-relevant data (composition, physical and chemical properties, microbiological quality, impurities, stability, normal and reasonably foreseeable use, exposure, toxicology, undesirable effects). Part B is the qualified safety assessor's reasoned conclusion, with warnings and instructions for use. The CPSR sits inside the Product Information File (PIF) held by the Responsible Person and must be updated when the product, composition or scientific evidence changes.

    See how Worldover assembles the PIF
    • Required under Annex I of EU 1223/2009 (and UK equivalent)
    • Part A: safety data (composition, exposure, toxicology, microbiology)
    • Part B: safety assessor's conclusion, warnings, instructions
    • Signed by a qualified safety assessor (pharmacist, toxicologist, or equivalent)
    • Held in the PIF, available to authorities on request
    • Updated when product, composition or scientific evidence changes

    How this connects to Worldover

    Managing INCI, PIF, CPSR and CPNP across a growing product range?

    Worldover holds INCI, formulation, PIF, CPSR, CPNP, SCPN and MoCRA on one substance-first record, with Willow AI drafting and filing on your live data.

    See AI ERP for cosmetics

    Part A: the data

    Part A is the dossier of safety-relevant data: qualitative and quantitative composition, physical and chemical characteristics, microbiological quality, impurities and traces of forbidden substances, stability, packaging, normal and reasonably foreseeable use, exposure to the product and to each substance, toxicological profile of each substance, undesirable and serious undesirable effects, and any other information on the product. It is a structured evidence file, not a marketing document.

    Part B: the assessment

    Part B is the qualified safety assessor's reasoned conclusion: a safety assessment based on Part A, with warnings and instructions for use, a justified statement on the safety of the product when used under normal or reasonably foreseeable conditions, and the assessor's credentials, signature and date. Without a signed Part B the PIF is incomplete and the product is not lawfully placed on the market.

    Who can sign

    The safety assessor must hold a qualification in pharmacy, toxicology, medicine or a similar related discipline, recognised in a Member State. The assessor can be in-house or external, but cannot be the same person whose work is being assessed without independence safeguards.

    Worldover for this

    CPSRs that update themselves

    Worldover assembles Part A from the formula, ingredient data and test results. Your safety assessor signs Part B. When composition or evidence changes, the draft re-assembles automatically.

    See cosmetic ERP software

    Keeping CPSRs current at scale

    A CPSR is not a one-time document. It must be updated when the formulation changes, new toxicological evidence becomes available, an ingredient is restricted, or undesirable effects accumulate. For a brand with hundreds of SKUs, this is structural data work, not legal work. Worldover holds the composition, the ingredient toxicology and the test results once, and re-generates the Part A draft whenever a relevant change is detected, so the assessor's time goes on judgement, not on assembly.

    What this means for your software stack

    A CPSR requires a complete and up-to-date product record: formula, safety assessment inputs, INCI list, clinical and toxicological data, and stability results. Managing this across multiple SKUs and markets in disconnected systems is where teams fall behind.

    How Worldover manages the CPSR

    Worldover maintains a live CPSR-ready product record for every SKU: formula, safety assessment inputs, INCI list and test results in one place. When a formula changes, the record updates automatically, and Willow flags when a CPSR needs review based on formulation or regulatory changes.

    FAQs

    Common questions.

    See Worldover on your operation.

    A 20-minute working session. Your SKUs, your customers, your documentation. No slide deck.